Strontium chloride Sr-89

DB09498ApprovedSmall molecule

Strontium chloride Sr-89 is a radiopharmaceutical agent used for the relief of bone pain in patients with painful skeletal metastases. Strontium chloride is mainly used in cases of metastatic castrate-resistant prostate cancer.

Chemical structure of Strontium chloride Sr-89
Mechanism
Curator reviewed · 2 references
Primary indication
Strontium-89 Chloride Injection is indicated as a paliative for the relief of bone pain in patients with skeletal metastases.Curator reviewed · 1 structured indication
Formula / weight
Cl2Sr · 159.81 g/mol (avg)
First approval
United States, 1993
Also known as
Strontium (89Sr) chloride · Strontium chloride Sr 89 · Strontium chloride, Sr-89 · Strontium-89 chloride
Code names
SMS-2PA

Resolves to

Structure
InChIKeyAHBGXTDRMVNFER-FCHARDOESA-LSMILES[Cl-].[Cl-].[89Sr++]

What you can answer from here — as of July 14, 2025

2TransportersSubstrate / inhibitor direction, not just membership
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
4Marketed productsAcross 2 countries and 4 labellers
Sign in
1ATC codeIncluding every combination product, plus 9 drug categories
Sign in
19+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Strontium chloride Sr-89, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account